Clinical Trials for Primary Biliary Cholangitis

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

NCT ID: NCT06730061

This clinical trial is studying a medication called elafibranor for adults in Japan who have a condition called Primary Biliary Cholangitis (PBC). PBC is a liver disease that damages the bile ducts...

A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis

NCT ID: NCT05050136

This clinical trial is studying a new medication called volixibat to see if it can help relieve itching (also known as pruritus) in patients with Primary Biliary Cholangitis (PBC), a liver disease....

A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

NCT ID: NCT06447168

This clinical trial is studying the effectiveness and safety of a medication called elafibranor for people with a liver disease known as Primary Biliary Cholangitis (PBC). PBC is a condition where ...

Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis

NCT ID: NCT06427395

This clinical trial is studying a medication called Saroglitazar Magnesium to see if it can help people with a condition known as Primary Biliary Cholangitis (PBC), which affects the liver. This tr...

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis

NCT ID: NCT06051617

This clinical trial is studying a medication called seladelpar to see how it affects patients with Primary Biliary Cholangitis (PBC) who also have a liver condition known as compensated cirrhosis. ...

LEOPARD Training and Validation Data Collection Study

NCT ID: NCT06675604

The LEOPARD Training and Validation Data Collection Study is a research project aimed at improving how doctors predict which patients on the waiting list for liver transplants are at the highest ri...

To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate

NCT ID: NCT06488911

A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury

NCT ID: NCT06888115

This clinical trial is studying a new medication called CS0159 to understand how it behaves in the body and to check its safety for people with liver problems, specifically those with a condition k...

Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

NCT ID: NCT04650243

This clinical trial is investigating whether it is safe and effective to reduce the dosage of a medication called Ursodeoxycholic Acid (UDCA) for patients with Primary Biliary Cholangitis (PBC) who...

Fenofibrate for Compensated Cirrhosis Patients with Primary Biliary Cholangitis

NCT ID: NCT05749822

This clinical trial is studying the effects of a medication called fenofibrate on patients with a liver condition known as Primary Biliary Cholangitis (PBC) who also have compensated cirrhosis. The...

Fenofibrate in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis

NCT ID: NCT06174402

This clinical trial is studying whether a medication called fenofibrate, when taken together with ursodeoxycholic acid (UDCA), can help lower levels of a substance called alkaline phosphatase in pe...

Fenofibrate Combined with Ursodeoxycholic Acid in Subjects with Primary Biliary Cholangitis

NCT ID: NCT05751967

This clinical trial is studying the effectiveness of combining two medications, fenofibrate and ursodeoxycholic acid (UDCA), to treat patients with Primary Biliary Cholangitis (PBC). UDCA is common...

TH104 for the Treatment of Pruritus in Primary Biliary Cholangitis

NCT ID: NCT06733519

This clinical trial is studying a new treatment called TH104 for people who experience severe itching, known as pruritus, caused by a liver condition called Primary Biliary Cholangitis (PBC). The t...

LEOPARD Prospective Validation Cohort 1

NCT ID: NCT06723275

The LEOPARD Prospective Validation Cohort 1 clinical trial is studying new ways to predict which patients with liver diseases are at the highest risk of needing a liver transplant and may not survi...

Fenofibrate in Patients with Primary Biliary Cholangitis (PBC)

NCT ID: NCT06365424

This clinical trial is studying a medication called fenofibrate in patients with a liver disease known as Primary Biliary Cholangitis (PBC). The main goal is to evaluate how safe and effective feno...

Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases

NCT ID: NCT06417398

This clinical trial is looking at a new treatment called UTAA09 injection for patients with certain autoimmune diseases that have not responded well to other treatments. Autoimmune diseases like sy...

Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule

NCT ID: NCT06371196

This clinical trial is investigating the effects of a herbal medicine called Baobao Dan Capsule on patients with Primary Biliary Cholangitis (PBC), a liver disease that can lead to high levels of a...

Detection Program for Patients With Primary Biliary Cholangitis Lost in the System

NCT ID: NCT05919433

This clinical trial is focused on finding patients with Primary Biliary Cholangitis (PBC) who may have been overlooked or lost to follow-up in the healthcare system. PBC is a chronic liver disease ...

National Database on Primary Biliary Cholangitis

NCT ID: NCT05151809

This clinical trial is focused on understanding Primary Biliary Cholangitis (PBC), a rare liver disease that happens when the body’s immune system attacks the bile ducts in the liver. The goal of t...